DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.61% to $9.17 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.46% to 51,947.25 and the NASDAQ Composite Index falling 0.64% to 24,975.82.
Corbus Pharmaceuticals Holdings Inc. closed 55.40% below its 52-week high of $20.56, which the company reached on October 20th.
Despite its losses, the stock outperformed some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 3.36% to $5.18, Fortress Biotech Inc. (FBIO) fell 2.62% to $3.34, and Viking Therapeutics Inc. (VKTX) fell 1.70% to $34.79.
Trading volume (172,580) remained 365,229 below its 50-day average volume of 537,809.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 24, 2026 17:21 ET (21:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.